These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14988822)

  • 1. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor.
    Willert RP; Woolf CJ; Hobson AR; Delaney C; Thompson DG; Aziz Q
    Gastroenterology; 2004 Mar; 126(3):683-92. PubMed ID: 14988822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans.
    Sarkar S; Hobson AR; Hughes A; Growcott J; Woolf CJ; Thompson DG; Aziz Q
    Gastroenterology; 2003 Jan; 124(1):18-25. PubMed ID: 12512025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
    Jørum E; Warncke T; Stubhaug A
    Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive cyclo-oxygenase-2 does not contribute to the development of human visceral pain hypersensitivity.
    Willert RP; Delaney C; Hobson AR; Thompson DG; Woolf CJ; Aziz Q
    Eur J Pain; 2006 Aug; 10(6):487-94. PubMed ID: 16122956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral ketamine on secondary hyperalgesia, thermal and mechanical pain thresholds, and sedation in humans.
    Mikkelsen S; Jørgensen H; Larsen PS; Brennum J; Dahl JB
    Reg Anesth Pain Med; 2000; 25(5):452-8. PubMed ID: 11009229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety increases acid-induced esophageal hyperalgesia.
    Sharma A; Van Oudenhove L; Paine P; Gregory L; Aziz Q
    Psychosom Med; 2010 Oct; 72(8):802-9. PubMed ID: 20841561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
    Warncke T; Stubhaug A; Jørum E
    Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
    Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
    Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery.
    Stubhaug A; Breivik H; Eide PK; Kreunen M; Foss A
    Acta Anaesthesiol Scand; 1997 Oct; 41(9):1124-32. PubMed ID: 9366932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autonomic response to human esophageal acidification and the development of hyperalgesia.
    Sharma A; Paine P; Rhodes S; Warburton F; Chua YC; Aziz Q
    Neurogastroenterol Motil; 2012 Jul; 24(7):e285-93. PubMed ID: 22672237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).
    Lemming D; Sörensen J; Graven-Nielsen T; Lauber R; Arendt-Nielsen L; Gerdle B
    Eur J Pain; 2007 Oct; 11(7):719-32. PubMed ID: 17197214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of esophageal hypersensitivity following experimental duodenal acidification.
    Hobson AR; Khan RW; Sarkar S; Furlong PL; Aziz Q
    Am J Gastroenterol; 2004 May; 99(5):813-20. PubMed ID: 15128342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ketamine therapy in the treatment of postamputation stump pain.
    Nikolajsen L; Hansen PO; Jensen TS
    Acta Anaesthesiol Scand; 1997 Mar; 41(3):427-9. PubMed ID: 9113191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification - evidence of central sensitization.
    Willert RP; Delaney C; Kelly K; Sharma A; Aziz Q; Hobson AR
    Neurogastroenterol Motil; 2007 Apr; 19(4):270-8. PubMed ID: 17391243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.
    Eide PK; Stubhaug A; Stenehjem AE
    Neurosurgery; 1995 Dec; 37(6):1080-7. PubMed ID: 8584148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans.
    Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB
    Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of esophageal afferent pathways by 5-HT3 receptor inhibition.
    Szczesniak MM; Fuentealba SE; Zhang T; Cook IJ
    Neurogastroenterol Motil; 2013 May; 25(5):383-8, e293. PubMed ID: 23360084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans.
    Mikkelsen S; Ilkjaer S; Brennum J; Borgbjerg FM; Dahl JB
    Anesthesiology; 1999 Jun; 90(6):1539-45. PubMed ID: 10360849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man.
    Warncke T; Stubhaug A; Jørum E
    Pain; 2000 Jun; 86(3):293-303. PubMed ID: 10812259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.